Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2010

Open Access 01-12-2010 | Research article

Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH)

Authors: Isabela M Benseñor, Paulo A Lotufo, Paulo R Menezes, Márcia Scazufca

Published in: BMC Public Health | Issue 1/2010

Login to get access

Abstract

Background

Several epidemiologic studies have shown a possible association between thyroid function and cognitive decline. Our aim was to evaluate the association of subclinical hyperthyroidism and dementia in a population sample of older people

Methods

A cross-sectional study - São Paulo Ageing & Health Study (SPAH) - in a population sample of low-income elderly people ≥ 65 years-old to evaluate presence of subclinical thyroid disease as a risk factor for dementia. Thyroid function was assessed using thyrotropic hormone and free-thyroxine as well as routine use of thyroid hormones or antithyroid medications. Cases of dementia were assessed using a harmonized one-phase dementia diagnostic procedure by the "10/66 Dementia Research Group" including Alzheimer's disease and vascular dementia. Logistic regression models were used to test a possible association between subclinical hyperthyroidism and dementia.

Results and discussion

Prevalence of dementia and of subclinical hyperthyroidism were respectively of 4.4% and 3.0%. After age adjustment, we found an association of subclinical hyperthyroidism and any type of dementia and vascular dementia (Odds Ratio, 4.1, 95% Confidence Interval [95% CI] 1.3-13.1, and 5.3 95% CI, 1.1-26.4; respectively). Analyzing data by gender, we found an association of subclinical hyperthyroidism with dementia and Alzheimer's disease only for men (OR, 8.0; 95% CI, 1.5-43.4; OR, 12.4; 95% CI, 1.2-128.4; respectively). No women with subclinical hypothyroidism presented Alzheimer's disease in the sample.

Conclusion

The results suggest a consistent association among people with subclinical hyperthyroidism and dementia.
Appendix
Available only for authorised users
Literature
1.
Gussekloo J, van Excel E, Craen AJ, Meinders AE, Frölich M, Westendorp RG: Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004, 292: 2591-2599. 10.1001/jama.292.21.2591.CrossRefPubMed
2.
Volpato S, Guralnik JM, Fried LP, Remaley AT, Cappola AR, Launer LJ: Serum thyroxine level and cognitive decline in euthyroid older women. Neurology. 2002, 58: 1055-61.CrossRefPubMed
3.
Ganguli M, Burmeister A, Seaberg EC, Belle S, DeKosky ST: Association between dementia and elevated tireotropic hormone (TSH): a community-based study. Biol Psychiatry. 1996, 40: 714-725. 10.1016/0006-3223(95)00489-0.CrossRefPubMed
4.
Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MB: Subclinical hyperthyroidism and the risk of dementia. The Rotterdam Study. Clin Endocrinol. 2000, 53: 733-737. 10.1046/j.1365-2265.2000.01146.x.CrossRef
5.
Wahlin A, Bunce D, Whalin TB: Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. Psychoneuroendocrinology. 2005, 30: 625-637. 10.1016/j.psyneuen.2005.01.010.CrossRefPubMed
6.
de Jong FJ, den Heijer T, Visser TJ, Rijke YB, Drexhage HA, Hofman A, Breteler MMB: Thyroid hormones, dementia, and atrophy of the medial temporal lobe. J Clin Endocrinol Metab. 2006, 91: 2569-2573. 10.1210/jc.2006-0449.CrossRefPubMed
7.
de Jong FJ, Masaki K, Remaley AT, Breteler MM, Petrovitch H, White LR, Launer LJ: Thyroid function, the risk of dementia and neuropathologic changes: The Honolulu-Asia Aging Study. Neurobiol Aging. 2007, 30: 600-606. 10.1016/j.neurobiolaging.2007.07.019.CrossRefPubMedPubMedCentral
8.
Hogervorst E, Huppert F, Matthews FE, Brayne C: Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology. 2008, 33: 1013-1022. 10.1016/j.psyneuen.2008.05.008.CrossRefPubMed
9.
Tan ZS, Beiser A, Vasan RS, Au R, Auerbach S, Kiel DP, Wolf PA, Seshadri S: Thyroid function and the risk of Alzheimer Disease. Arch Intern Med. 2008, 168: 1514-1520. 10.1001/archinte.168.14.1514.CrossRefPubMedPubMedCentral
10.
Scazufca M, Menezes PR, Vallada HP, et al: High prevalence of dementia among older adults from poor socio-economic background in São Paulo, Brazil. Int Psychogeriat. 2008, 20: 394-405. 10.1017/S1041610207005625.CrossRef
11.
Prince M, Acosta D, Chiu H, Scazufca M, Varghese M: Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet. 2003, 361: 909-917. 10.1016/S0140-6736(03)12772-9.CrossRefPubMed
12.
American Psychiatric Association: Diagnostic and Statistic Manual of Mental Disorders: DSM-IV. 1994, Washington DC: Donnelley & Sons Company
13.
Hall KS, Hendric HH, Brittain HM, et al: The development of a dementia screening interview in two distinct languages. Int J Methods Psychiatr Res. 1993, 361: 909-917.
14.
Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of neuropsychological battery. Neurology. 1994, 44: 609-614.CrossRefPubMed
15.
Copeland JR, Dewey ME, Griffiths-Jones HM: A computerized psychiatric Diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986, 16: 89-99.CrossRefPubMed
16.
Prince M, Acosta D, Chiu H, Scazufca M, Varghese M: Effects of education and culture on the validity of the Geriatric Mental State and its AGECAT algorithm. Br J Psychiatry. 2004, 185: 429-436. 10.1192/bjp.185.5.429.CrossRefPubMed
17.
Dewey ME, Copeland JR: Diagnosis of dementia from the history and etiology schedule. Int J Geriatr Psychiatry. 2001, 16: 912-917. 10.1002/gps.446.CrossRefPubMed
18.
Prince M, Ferri CP, Acosta D, Alabanese E, Arizaga R, Dewey M, Gavrilova SI, Guerra M, Huang Y, Jacob KS, Krishnamoorthy ES, McKeigue P, Rodriguez JL, Salas A, Sosa AL, Sousa RM, Stewart R, Uwakwe R: The protocols for the 10/66 dementia research group population-based research program. BMC Public Health. 2007, 7: 165-10.1186/1471-2458-7-165.CrossRefPubMedPubMedCentral
19.
20.
American Diabetes Association: Diabetes Care. 2006, 29 (suppl 1): s43-s48.
21.
Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, Gureje O, Rodenberg CA, Baiyewu O, Musick BS: Prevalence of Alzheimer's disease and dementia in two communities: Nigerian African and African Americans. Am J Psychiatry. 1995, 152: 1485-1492.CrossRefPubMed
22.
Hendrie HC, Ogunniyi AO, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, Gao S, Evans RM, Ogunseyinde AO, Adeyinka AO, Musick B, Hui SL: Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001, 285: 739-747. 10.1001/jama.285.6.739.CrossRefPubMed
23.
Herrera E, Caramelli P, Silveira AS, Nitrini R: Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord. 2002, 16: 103-108. 10.1097/00002093-200204000-00007.CrossRefPubMed
24.
Nitrini R, Caramelli P, Herrera E, Bahia VS, Caixeta LF, Radanovic M, Anghinah R, Charchat-Fichman H, Porto CS, Carthery MT, Hartmann AP, Huang N, Smid J, Lima EP, Takada LT, Takahashi DY: Incidence of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord. 2004, 18: 241-246.PubMed
25.
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa , Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease International: Global Prevalence of Dementia a Delphi consensus study. Lancet. 2005, 366: 2112-2137. 10.1016/S0140-6736(05)67889-0.CrossRefPubMedPubMedCentral
26.
Pretell EA, Delange F, Hostalek U, Corigliano S, Barreda L, Higa AM, Altschuller N, Barragan D, Cevallos JL, Gonzales O, Jara JA, Medeiros-Neto G, Montes JA, Muzzo S, Pacheco VM, Codero L: Iodine nutrition improves in Latin America. Thyroid. 2004, 14: 590-599. 10.1089/1050725041692909.CrossRefPubMed
27.
Hoogendoorn EH, Hermus AR, de Vegt F, Ross HA, Verbeek AL, Kiemeney LA, Swinkels DW, Sweep FC, den Heijer M: Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem. 2006, 52: 104-11. 10.1373/clinchem.2005.055194.CrossRefPubMed
28.
Carle A, Laurberg P, Pedersen IB, Knudsen N, Perrild H, Ovesen L, Rasmussen LB, Jorgensen T: Epidemiology of subtypes of hypothyroidism in Denmark. Eur J Endocrinol. 2006, 154: 21-28. 10.1530/eje.1.02068.CrossRefPubMed
29.
Teng W, Shan Z, Teng X, Guan H, li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C: Effect of iodine intake on thyroid diseases in China. NEJM. 2006, 354: 2783-2793. 10.1056/NEJMoa054022.CrossRefPubMed
30.
Freire-Maia DV: Sex and age prevalence of endemic epidemiological study. J Hyg Epidemiol Microbiol Immunol. 1981, 25: 401-406.PubMed
31.
Correa Filho HR, Vieira JB, Silva YS, Coelho GE, Cavalcante F dos A, Pereira M da P: Endemic goiter prevalence survey in Brazilian schoolchildren 6 to 14 years old, 1994-1996. Rev Panam Salud Publica. 2002, 12: 317-316. 10.1590/S1020-49892002001100005.CrossRefPubMed
32.
33.
Batista Filho M, Rissin A: Nutritional transition in Brazil: geographic and temporal trends. Cad Saúde Pública. 2003, 19: 181-191.CrossRef
34.
Duarte GC, Tomimori EK, Boriolli RA, Ferreira JE, Catarino RM, Camargo RY, Medeiros-Neto G: Echographic evaluation of the thyroid gland and urinary iodine concentration in school children from various regions in the state of São Paulo, Brazil. Arq Bras Endocrinol Metabol. 2005, 48: 842-848.
35.
Marino MA, Martins LC, Esteves RZ, Kasamatsu TS, Maciel RM: A Urinary iodine in patients with auto-immune thyroid disorders in Santo André, SP, is comparable to normal controls and has been steady for the last 10 years. Arq Bras Endocrinol Metab. 2009, 53: 55-63. 10.1590/S0004-27302009000100009.CrossRef
36.
de Pontes AA, Rocha AM, Leite DF, Lessa AF, Adan LF: Salt iodation in Brazil, a controversial subject. Arq Bras Endocrinol Metab. 2009, 53: 113-114.CrossRef
37.
Helfand M, Redfern CC: Screening for thyroid disease: an update. Clinical Guideline, Part 2. Ann Intern Med. 1998, 129: 144-158.CrossRefPubMed
38.
Lotufo PA: Premature mortality from heart diseases in Brazil. A comparison with other countries. Arq Bras Cardiol. 1998, 70: 321-325. 10.1590/S0066-782X1998000500003.CrossRefPubMed
39.
Lotufo PA, Bensenor IM: Stroke mortality in Brazil: one example of delayed epidemiological cardiovascular transition. Int J Stroke. 2009, 4: 40-41. 10.1111/j.1747-4949.2009.00240.x.CrossRefPubMed
40.
Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Oden A, Svanborg A: 15-year longitudinal study of blood pressure and dementia. Lancet. 1996, 347: 1141-1145. 10.1016/S0140-6736(96)90608-X.CrossRefPubMed
41.
Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, van Duijn CN, Van Broeckhoven C, Grobbee DE: Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997, 349: 151-154. 10.1016/S0140-6736(96)09328-2.CrossRefPubMed
42.
Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001, 322: 1447-1451. 10.1136/bmj.322.7300.1447.CrossRefPubMedPubMedCentral
43.
Gandra YR: O bócio endêmico no Estado de São Paulo. Arquivos de Hygiene e Saúde Pública de São Paulo. 1966, 20: 167-181. in PortugueseCrossRef
Metadata
Title
Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH)
Authors
Isabela M Benseñor
Paulo A Lotufo
Paulo R Menezes
Márcia Scazufca
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2010
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-10-298

Other articles of this Issue 1/2010

BMC Public Health 1/2010 Go to the issue

Study protocol

Evaluation of health promotion in schools: a realistic evaluation approach using mixed methods

Research article

Security lies in obedience - Voices of young women of a slum in Pakistan

Research article

Running away experience and psychoactive substance use among adolescents in Taiwan: multi-city street outreach survey

Research article

Peer substance use overestimation among French university students: a cross-sectional survey

Research article

Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model

Research article

Trajectories of maternal symptoms of anxiety and depression. A 13-year longitudinal study of a population-based sample